Table 1 Demography and baseline characteristics (ITT population, N = 76)
Mean (SD), N = 76 | ||
Age at informed consent, years | 64.80 (8.39) | |
Height, cm | 168.22 (8.55) | |
Weight, kg | 75.45 (15.52) | |
BMI, kg/m2 | 26.65 (5.05) | |
Smoking history Number of pack-years, years | 50.13 (23.28) | |
Years since COPD diagnosis | 5.17 (5.24) | |
Age at COPD diagnosis, years | 60.16 (10.96) | |
FEV1 % predicted | 56.09 (13.28) | |
FEV1*, L | 1.50 (0.45) | |
FVC*, L | 2.95 (0.89) | |
IC, L | 2.45 (0.69) | |
Total Lung Capacity (TLC), L | 7.13 (1.42) | |
TLC % of predicted normal value | 120.68 (18.75) | |
Airway Resistance (Raw) | 6.73 (3.19) | |
Raw % of predicted normal value | 210.99 (117.11) | |
Hyperinflation IC/TLC | 0.35 (0.09) | |
N (%) | ||
Gender | Male | 45 (59.2) |
Female | 31 (40.8) | |
Number of patients with current medical condition | CAD | 7 (9.2) |
Hypertension | 29 (38.2) | |
Diabetes mellitus | 4 (5.3) | |
Number of patients according COPD GOLD-stage | Stage I | 8 (10.5) |
Stage II | 31 (40.8) | |
Stage III | 30 (39.5) | |
Stage IV | 7 (9.2) | |